Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
c19early.org COVID-19 treatment researchSpirulinaSpirulina (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

 
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Reis (RCT) 2% 0.98 [0.06-15.6] death 1/569 1/557 low dose, data anomaly Improvement, RR [CI] Treatment Control Tau​2 = 0.00, I​2 = 0.0%, p = 0.99 Early treatment 2% 0.98 [0.06-15.6] 1/569 1/557 2% lower risk Aghasadeghi (RCT) 85% 0.15 [0.06-0.40] death 47 (n) 52 (n) Improvement, RR [CI] Treatment Control Shadnoush (DB RCT) -3% 1.03 [0.55-1.89] death 68 (n) 58 (n) ICU patients Tau​2 = 1.66, I​2 = 90.6%, p = 0.36 Late treatment 59% 0.41 [0.06-2.68] 115 (n) 110 (n) 59% lower risk All studies 51% 0.49 [0.10-2.25] 1/684 1/667 51% lower risk 3 spirulina COVID-19 studies c19early.org November 2024 Tau​2 = 1.33, I​2 = 81.4%, p = 0.36 Effect extraction pre-specified(most serious outcome) Favors spirulina Favors control
Sep 8
Shadnoush et al., Journal of Cellular and Molecular Anesthesia, doi:10.5812/jcma-149015 Effects of Spirulina platensis Supplementation on COVID-19 Severity in Critically Ill Patients: A Randomized Clinical Trial
3% higher mortality (p=0.93), 26% shorter ICU admission (p=0.007), 17% lower need for oxygen therapy (p=0.64), and 20% shorter hospitalization (p=0.001). RCT 192 critically ill COVID-19 ICU patients showing reduced SOFA score, hospital stay and ICU stay with spirulina supplementation (5g/day), but no significant difference in mortality, NEWS2 score, APACHE score, NUTRIC score, or respirato..
Aug 15
Reis et al., The American Journal of Clinical Nutrition, doi:10.1016/j.ajcnut.2024.06.016 Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER randomized trial
21% higher progression (p=0.29). RCT 1,126 patients in Brazil showing no significant differences with low dose spirulina. The dose used was 7.6 times lower than the dose used by [Aghasadeghi] which shows significantly lower mortality. eFigure 1 shows 12 events in the tr..
Apr 8
Aghasadeghi et al., Frontiers in Immunology, doi:10.3389/fimmu.2024.1332425 Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial
85% lower mortality (p=0.0002) and 75% higher hospital discharge (p=0.003). RCT 189 hospitalized COVID-19 patients showing lower mortality and faster recovery with spirulina. Spirulina treatment also resulted in greater reductions in inflammatory markers such as IL-6, TNF-a, IP-10, CRP, ESR, and ferritin. All pat..
Jul 31
2023
Rohilla et al., Stresses, doi:10.3390/stresses3030039 Algae Polysaccharides (Carrageenan and Alginate)—A Treasure-Trove of Antiviral Compounds: An In Silico Approach to Identify Potential Candidates for Inhibition of S1-RBD Spike Protein of SARS-CoV-2
In Silico study showing the potential antiviral activity of algal polysaccharides alginate and carrageenan against SARS-CoV-2. Molecular docking analyses predict that alginate and carrageenan can bind to and inhibit the viral S1-RBD spike..
Jul 3
2023
Pantazopoulos et al., Journal of Personalized Medicine, doi:10.3390/jpm13071093 A Hypertonic Seawater Nasal Irrigation Solution Containing Algal and Herbal Natural Ingredients Reduces Viral Load and SARS-CoV-2 Detection Time in the Nasal Cavity
42% improved viral clearance (p=0.06). RCT 56 severe COVID-19 patients, showing significantly decreased viral load with Sinomarin Plus Algae nasal irrigation. Sinomarin Plus Algae is a hypertonic seawater solution with algal and herbal natural ingredients with a pH of 7.5-8..
May 30
2022
Mazokopakis et al., European Journal of Medical and Health Sciences, doi:10.24018/ejmed.2022.4.3.1355 The Contribution of Spirulina Platensis Supplementation on COVID-19 Prevention and Hospitalization
90% lower hospitalization (p<0.0001) and 81% fewer symptomatic cases (p<0.0001). Analysis of 186 adults in Greece showing a significant reduction in COVID-19 cases and hospitalizations with 6 g/day spirulina treatment for 6 months. Authors do not provide baseline details for each group.
Oct 25
2021
Leal-Martínez et al., International Journal of Environmental Research and Public Health, doi:10.3390/ijerph19031172 (date from preprint) Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial
86% lower mortality (p=0.03) and 57% lower ventilation (p=0.31). 80 patient RCT with 40 patients treated with a comprehensive regimen of nutritional support, showing significantly lower mortality with treatment. Treatment contained cholecalciferol, vitamin C, zinc, spirulina maxima, folic acid, glutami..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit